Top Stories
Latest Coverage
NaPi2b Emerges as a New Ovarian Cancer Target: Two ADC Therapies Report Encouraging Clinical Data
At the 2026 ASCO Annual Meeting, new developments once again drew attention in the ovarian cancer ADC field.
At the 2026 ASCO Annual Meeting, new developments once again drew attention in the ovarian cancer ADC field.
How Can a Box of Medicine Travel Thousands of Miles? The Power Behind Pharmaceutical Logistics Coverage
When a patient receives a box of medicine from a hospital pharmacy, they rarely realize that the medication may have ...
When a patient receives a box of medicine from a hospital pharmacy, they rarely realize that the medication may have ...
Why Do Patients Often Have More Treatment Options After a Drug Patent Expires?
In the healthcare field, people frequently hear terms such as “drug patent expiration,” “domestic alternatives,” “gen...
In the healthcare field, people frequently hear terms such as “drug patent expiration,” “domestic alternatives,” “gen...
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
When APIs Are Controlled by a Few Companies: How Risks Spread Across the Pharmaceutical Supply Chain
In the global pharmaceutical industry, active pharmaceutical ingredients (APIs) are often one of the most overlooked ...
In the global pharmaceutical industry, active pharmaceutical ingredients (APIs) are often one of the most overlooked ...
How Is the Rare Disease Drug Supply Chain Changing as Patient Assistance Programs Expand?
As precision medicine and innovative drug development continue to advance, an increasing number of treatment options ...
As precision medicine and innovative drug development continue to advance, an increasing number of treatment options ...
